Internist and Nephrologist specialized in GN and Hypertension.Assistant Professor at @kauedu_sa and part time Consultant at @HMG
Jeddah
Joined January 2011
- Tweets17.9K
- Following587
- Followers1.3K
- Likes3.3K
Naif Alghamdi retweeted
New for 2027: the GlomCon Transplant Scholars Program.
A 10-Month online program dedicated to advancing education in kidney transplantation: From candidate evaluation to post-transplant management, including pathology, protocols, complications, and living donor assessment.
Directed by Nay Seif, MD, MS, and Anshul Bhalla, MD. Built for fellows and practicing nephrologists.
Applications open November 9, 2026.
Learn more at glomcon.org
#Nephrology #KidneyTransplant #NephTwitter #GlomCon
Naif Alghamdi retweeted
The Kidney Pathology Certificate Program returns for its 2027 cohort.
Twelve months, six modules, from biopsy basics to allograft pathology: Live case webinars led by renal pathologists and nephrologists, pre-recorded lectures, and a certificate upon completion of program.
Directed by Vanesa Bijol, MD and Ibrahim Batal, MD.
Applications open on October 26, 2026.
Learn more at glomcon.org
#RenalPathology #Nephrology #Nephropathology #GlomCon
Naif Alghamdi retweeted
Now off to April/BAFF targeting therapies in IgAN by Dr. Ali Mehdi @CleClinicKidney @GlomCon @glomconarabia
Naif Alghamdi retweeted
A brilliant @glomconarabia session on IgA Nephropathy by the amazing Dr. Ali Mehdi @CleClinicKidney @GlomCon
Naif Alghamdi retweeted
We are excited to host another session in the GlomCon Arabia Seminar Series on Friday, October 9th, 2026.
This session will feature an expert presentation by Dr. Ali Mehdi MD, MEd, FACP, FASN, with Dr. Naif Ali A A Alghamdi, MBBS, FASN, CHS (AHSCP) as moderator titled “IgA Nephropathy: Where We Are and Where We Are Going.”
Meeting details:
glomcon.zoom.us
Zoom ID: 884 4208 1901
Passcode: 100499
Find event details at glomcon.org/arabia-glomcon
We invite you to join us for this informative session and connect with colleagues from around the world!
#GlomCon #GlomConArabia #IgANephropathy #Nephrology #KidneyHealth #KidneyEducation #NephrologyEducation #MedicalCommunity #GlobalMedicine
Naif Alghamdi retweeted
We are excited to host another session in the GlomCon Arabia Seminar Series tomorrow Friday, October 9, 2026
This session will feature an expert presentation by Dr. Ali Mehdi “IgA Nephropathy: Where We Are and Where We Are Going”
Meeting details:
glomcon.zoom.us
Meeting ID: 884 4208 1901
Passcode: 100499
@GlomCon @glomconarabia #NephrologyEducation #MedicalCommunity #GlobalMedicine @CleClinicKidney
Naif Alghamdi retweeted
DIALIZE-Outcomes data showed sodium zirconium cyclosilicate did not increase edema, heart failure, hypertension, or weight gain versus placebo in hemodialysis patients, according to study in #ASNKidney360. kidney.pub/KID1330
Naif Alghamdi retweeted
Causes of Infection-Related Glomerulonephritis
From Dr. Hala Kassouf's lecture @glomconarabia
Prof. Hala Kfouri is amazingly discussing this interesting yet confusing topic of infection-related kidney disease @glomconarabia @GlomCon
Naif Alghamdi retweeted
Join us today for an expert presentation by Dr. Hala Kfoury Kassouf titled “Infection-related Kidney Injury: Mechanisms, Implications, and Pathological Insights”
Meeting details:
glomcon.zoom.us
Meeting ID: 884 4208 1901
Passcode: 100499
lnkd.in/d5Ta7sQg
Do not miss this interesting topic coming up Friday
We are excited to host another session in the GlomCon Arabia Seminar Series on Friday, September 18, 2026.
This session will feature an expert presentation by Dr. Hala Kfoury Kassouf, MD, EMBA titled “Infection-related Kidney Injury: Mechanisms, Implications, and Pathological Insights”
Meeting details:
glomcon.zoom.us
Meeting ID: 884 4208 1901
Passcode: 100499
lnkd.in/d5Ta7sQg
We invite you to join us for this informative session and connect with colleagues from around the world!
#GlomCon #GlomConArabia #NephrologyEducation #MedicalCommunity #GlobalMedicine
Naif Alghamdi retweeted
Dr S Almaani reviews the data on PLEX and provides his perspective with AAV #WUSTLneph @ting2li
Naif Alghamdi retweeted
Benefits of SGLT2i exceed serious harms regardless of polypharmacy status, with greatest absolute effects in patients with higher medication burden
New CREDENCE analysis from @emilykyeung in @NDTsocial doi.org/10.1093/ndt/gfag203
Naif Alghamdi retweeted
Now open access in @NDTsocial @fervenzaf
Protocol biopsy in class III/IV lupus nephritis: barking up the wrong tree!
🧐Evaluating activity in LN is not done by performing protocol kidney biopsies, but by looking at the serological activity.
▶️academic.oup.com/ndt/article…
Synergy
EDITORIAL: Finerenone Plus Empagliflozin: How Low Can We Go, and How Much Does Blood Pressure Matter?
ahajrnls.org/4wJGtGl
